Skip to content
20-F

Annual Report (Foreign)

CELLYAN BIOTECHNOLOGY CO., LTD HKPD

0001213900-25-076725

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Mar 31, 2025 10.21M sh
Shares Diluted FY 2025 · Mar 31, 2024 7.37M sh
Shares Diluted FY 2025 · Mar 31, 2023 6.84M sh
Shares Outstanding FY 2025 · Mar 31, 2025 11M sh
Operating Cash Flow FY 2025 · Mar 31, 2025 $569.21K
Operating Cash Flow FY 2025 · Mar 31, 2024 −$394.33K
Operating Cash Flow FY 2025 · Mar 31, 2023 $1.73M
Cash And Equivalents FY 2025 · Mar 31, 2025 $748.72K
Cash And Equivalents FY 2025 · Mar 31, 2024 $619.58K
Stockholders Equity FY 2025 · Mar 31, 2025 $4.99M
Stockholders Equity FY 2025 · Mar 31, 2024 $4.25M
Stockholders Equity FY 2025 · Mar 31, 2023 $585.24K
Stockholders Equity FY 2025 · Mar 31, 2022 −$413.59K
Current Liabilities FY 2025 · Mar 31, 2025 $2.92M
Current Liabilities FY 2025 · Mar 31, 2024 $3.18M
Total Liabilities FY 2025 · Mar 31, 2025 $4.43M
Total Liabilities FY 2025 · Mar 31, 2024 $4.41M
Current Assets FY 2025 · Mar 31, 2025 $8.73M
Current Assets FY 2025 · Mar 31, 2024 $7.8M
Total Assets FY 2025 · Mar 31, 2025 $9.42M
Total Assets FY 2025 · Mar 31, 2024 $8.67M
Eps Diluted FY 2025 · Mar 31, 2025 −$0.00
Eps Diluted FY 2025 · Mar 31, 2024 $0.18
Eps Diluted FY 2025 · Mar 31, 2023 $0.15
Eps Basic FY 2025 · Mar 31, 2025 −$0.00
Eps Basic FY 2025 · Mar 31, 2024 $0.18
Eps Basic FY 2025 · Mar 31, 2023 $0.15
Sga Expense FY 2025 · Mar 31, 2025 $2.22M
Sga Expense FY 2025 · Mar 31, 2024 $1.89M
Sga Expense FY 2025 · Mar 31, 2023 $1.76M
Net Income FY 2025 · Mar 31, 2025 −$27.06K
Net Income FY 2025 · Mar 31, 2024 $1.33M
Net Income FY 2025 · Mar 31, 2023 $998.2K
Operating Income FY 2025 · Mar 31, 2025 −$2.28M
Operating Income FY 2025 · Mar 31, 2024 −$1.95M
Operating Income FY 2025 · Mar 31, 2023 −$1.79M
Gross Profit FY 2025 · Mar 31, 2025 $2.42M
Gross Profit FY 2025 · Mar 31, 2024 $3.56M
Gross Profit FY 2025 · Mar 31, 2023 $2.74M
Cost Of Revenue FY 2025 · Mar 31, 2025 $17.9M
Cost Of Revenue FY 2025 · Mar 31, 2024 $13.13M
Cost Of Revenue FY 2025 · Mar 31, 2023 $9.82M
Revenue FY 2025 · Mar 31, 2025 $20.31M
Revenue FY 2025 · Mar 31, 2024 $16.69M
Revenue FY 2025 · Mar 31, 2023 $12.56M